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The catenin p120 (hereafter p120ctn) was first identified as a Src kinase substrate and subsequently characterized as an Armadillo catenin
member of the cell–cell adhesion cadherin–catenin complex. In the past decade, many studies have revealed roles for p120ctn in regulating Rho
family GTPase activity and E-cadherin stability and turnover, events that occur predominantly at the plasma membrane or in the cytoplasm.
However, the recent discovery of the nuclear BTB/POZ-ZF transcription factor Kaiso as a p120ctn binding partner, coupled with the detection of
p120ctn in the nucleus of some cell lines and tumor tissues, suggested that like the classical β-catenin, p120ctn undergoes nucleocytoplasmic
trafficking and regulates gene expression. Indeed, p120ctn has a classic nuclear localization signal and does traffic to the nucleus. Moreover,
nuclear p120ctn regulates Kaiso DNA-binding and transcriptional activity, similar to β-catenin's modulation of TCF/LEF transcription activity.
However unlike β-catenin, p120ctn does not appear to be a transcriptional activator. Hence it remains to be determined whether the sole role of
nuclear p120ctn is regulation of Kaiso or whether p120ctn binds and regulates other transcription factors or nuclear proteins.
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For over a decade it was thought that the Armadillo catenins
(β-, γ-, and p120) functioned solely as cell-adhesion cofactors
for a class of transmembrane cell adhesion molecules known as
the classical cadherins. However, increasing evidence has
revealed that the Armadillo catenins are multifunctional
signaling molecules that also shuttle between the cytoplasm
and nucleus to regulate gene expression via their interaction
with DNA-binding transcription factors. This is best exempli-
fied by the classical β-catenin which also functions as a
downstream effector of the canonical Wnt signaling pathway,
and translocates to the nucleus to activate gene expression in
conjunction with the Lef/TCF family of transcription factors
(reviewed in [1,2]). In contrast to β-catenin, a gene expression
role for the much less characterized p120ctn was first hinted at
when the novel transcription factor, Kaiso, was identified as a
p120ctn-specific binding partner [3].
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whose tyrosine phosphorylation correlated with the Src-
transformed phenotype [4,5]. However, instead of the expected
SH2 and SH3 domains characteristic of most tyrosine kinase
signaling molecules, p120ctn possessed the protein–protein
interaction Arm domain found in the Drosophila Armadillo
protein and its vertebrate homolog β-catenin [6] (Fig. 1). In fact,
it was this structural similarity to β-catenin that led to the
discovery that p120ctn was a novel catenin component of the
E-cadherin–catenin complex [4]. However, unlike the classical
catenins, β- and γ- (plakoglobin), that compete for binding
to a highly conserved E-cadherin catenin-binding domain
(CBD) and link E-cadherin to the actin cytoskeleton via
their simultaneous interaction with α-catenin, p120ctn bound
E-cadherin at a distinct conserved juxtamembrane domain
(JMD) [7–10]. For several years the role of p120ctn in the
cadherin–catenin complex remained unknown, but since the
JMDwas linked to cadherin stability and clustering [8,9,11–13],
it was postulated that perhaps p120ctn played a role in these
activities. In the past 5 years, several independent studies have
now convincingly demonstrated that the role of p120ctn in the
cadherin–catenin complex is to regulate cadherin stability and
turnover [14–16]. Hence, unlike β-catenin and plakoglobin,
Fig. 1. Schematic representation of p120ctn and its nuclear binding partner Kaiso. Structural and functional domains are highlighted. (A) p120ctn is characterized by a
protein–protein interaction Armadillo domain containing ten 42-amino acid Armadillo repeats. This domain mediates interaction with cadherins and Kaiso, perhaps in
a mutually exclusive manner. An amino-terminal coiled domain may participate in protein–protein interactions whereas the p120ctn phosphorylation domain (asterisks)
is involved in integrating upstream kinase signaling and regulating p120ctn function. The nuclear localization signal (NLS) and Nuclear export signals (NES) are
highlighted. (B) Kaiso is characterized by an amino-terminal POZ protein–protein interaction domain and a carboxy-terminal zinc finger domain comprised of three
C2H2 type zinc fingers (ZF). The nuclear localization signal (NLS) and two highly acidic regions (AR) are also indicated. Kaiso also has several putative proline-
dependent serine/threonine phosphorylation sites (asterisks).
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and adhesion rather than as a structural “anchor” in AJ. This
aspect of p120ctn function is reviewed extensively elsewhere in
this issue (Xiao et al.).
During the initial characterization of p120ctn, it became
apparent that p120ctn differed from classical catenins in other
ways. For example, p120ctn did not bind α-catenin or the
tumor suppressor Adenomatous polyposis coli (APC) [7].
Since the Armadillo domain was implicated in protein–protein
interactions and p120ctn was structurally similar to β-catenin,
one possibility was that p120ctn interacted with unique binding
partners, which may or may not be homologs of APC and
α-catenin. A yeast 2-hybrid screen using the p120ctn Armadillo
domain as bait led to the identification of several p120ctn-
specific interacting binding partners (JM Daniel and AB
Reynolds, unpublished data). The most frequent gene
identified in the screen encoded a novel member of the
BTB/POZ (Broad complex, Tramtrak, Bric à brac/Pox virus
and zinc finger)-zinc finger family of transcription factors and
was named Kaiso after the rhythmic Caribbean calypso music
[3]. Kaiso specifically interacted with p120ctn but no other
known component of the E-cadherin/catenin complex. More
recently however, Kaiso was also found to interact with the
p120ctn-related protein, δ-catenin [17]. While this raises the
possibility that Kaiso plays a unique role with p120ctn
subfamily members or vice versa, it should be noted that co-
immunoprecipitation studies with another p120ctn subfamily
member, ARVCF, failed to detect an interaction with Kaiso
(JM Daniel and AB Reynolds, unpublished data). It is
currently unknown whether Kaiso interacts with other
p120ctn subfamily members such as p0071 and plakophillins.The discovery of the p120ctn–Kaiso interaction provided the
first hint that p120ctn, like β-catenin, may be a multifunctional
catenin with roles in cell adhesion, signaling and gene
expression. However, at that time and in contrast to β-catenin,
p120ctn had seldom been detected in the nucleus of cell lines.
Now, several labs have reported the detection of nuclear p120ctn
in various human cell lines and tumor tissues, and a role for
p120ctn in regulating gene expression has also been demon-
strated. This review article focuses on our current knowledge of
nuclear p120ctn and its binding partner Kaiso, and their roles in
gene expression.
2. Nucleocytoplasmic trafficking of p120ctn
Although the p120ctn–Kaiso interaction was reminiscent of
the association between β-catenin and the T-cell factor/Lym-
phoid enhancing factor (TCF/LEF) transcription factor, many
studies initially failed to detect any nuclear p120ctn in tumor cell
lines or tissues. However, treatment of various cell lines with
Leptomycin B (LMB), a specific inhibitor of CRM-1 mediated
nuclear export that causes nuclear accumulation of proteins
utilizing this pathway, resulted in nuclear accumulation of
p120ctn [18–20]. These observations suggested that perhaps the
failure to detect nuclear p120ctn was because it was rapidly and
efficiently exported from the nucleus, and that the nuclear
localization of p120ctn was a dynamic and tightly regulated
process. These preliminary data further reinforced the idea that
p120ctn had a nuclear function and indicated that (i) p120ctn was
capable of entering the nucleus but it was being rapidly shuttled
out of the nucleus so that a nuclear fraction was seldom
detected, and (ii) p120ctn utilized a LMB-sensitive (e.g. CRM-
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stable interaction between p120ctn and CRM-1 has yet to be
demonstrated in vivo or in vitro.
The nuclear localization of p120ctn upon LMB treatment,
coupled with the detection of the p120ctn–Kaiso interaction
predominantly in nuclear rather than cytoplasmic fractions from
various tumor and non-tumor-derived cell lines (our unpub-
lished data) confirmed the existence of a nuclear p120ctn pool.
To determine whether the nuclear localization of p120ctn was
due to a specific nuclear localization signal (NLS) or due simply
to the presence of the Armadillo domain, Kelly et al. [18]
performed p120ctn NLS-mapping experiments. The authors
determined that the nuclear localization of p120ctn was
mediated by a specific and highly basic nuclear localization
signal, KKGKGKKP, that is located between p120ctn Armadillo
repeats 6 and 7 [18] (Fig. 1). However in an independent study
by Roczniak-Ferguson et al. [19], it was found that deletion of
this NLS and a second putative NLS had no significant effect on
p120ctn nuclear localization. Roczniak-Ferguson et al. further
reported that the core nucleocytoplasmic shuttling properties of
p120ctn were conferred by its Armadillo domain, and that Arm
repeats 3 and 5 were necessary for the nuclear localization of
p120ctn isoform 3A [19]. These apparently contradictory
findings of Kelly et al. [18] and Roczniak-Ferguson et al. [19]
may be explained by the fact that, (i) in the Roczniak-Ferguson
study, the putative NLSs were deleted rather than mutated and
the deletion may have produced a conformational change that
affected additional properties of p120ctn and (ii) different cell
types and p120ctn isoforms were used in the two studies. It is
also possible that both studies are correct since Kelly and
colleagues never excluded the possibility of additional classical
or unique NLSs in p120ctn. Nevertheless, both studies conclude
that although p120ctn is seldom detected in the nucleus of cell
lines or tumor tissue, p120ctn undergoes nucleocytoplasmic
shuttling. Furthermore, the possibility exists that p120ctn
possesses intrinsic nuclear shuttling activity conferred by its
Arm domain. This raises the question: does p120ctn interact
directly with Importin-α or does it function itself as an Importin
and interact directly with the nuclear pore?
Although it was first thought that the main function of the
Armadillo repeat domain was to mediate protein–protein
interactions between Armadillo catenins and their binding
partners, increasing evidence suggests that the Arm domain
may also play a role in nuclear localization. First, the Armadillo
domain is the sole functional domain in Importin-α, the nuclear
trafficking protein that plays a key role in the nuclear import of
NLS-bearing proteins [21]. Second, it is now evident that many
Armadillo domain-containing proteins (the tumor suppressor
APC [22,23], β-catenin [24], the desmosomal proteins
plakophillins 1 and 2 [25–29], and the yeast SRP1 [30–32])
display nuclear localization. Third, it is intriguing to note that β-
catenin binds directly to the Importin-β subunit of the Importin-
α/β heterodimer and is imported into the nucleus in the absence
of Importin-α [24,33]. Collectively these reports lend credence
to the idea that the Armadillo domain is sufficient for nuclear
localization of Arm-domain containing proteins and that
perhaps p120ctn and most Armadillo family proteins alsofunction as nuclear transport proteins. It is therefore noteworthy
that the yeast SRP1 appears to act as an Importin-α for LEF
[31,34]. Another possibility however is that the Armadillo
domain first evolved as a nucleocytoplasmic trafficking
protein–protein interaction domain and its role in cell adhesion
and signaling evolved later. This hypothesis is supported by the
observation that many Arm domain-containing proteins are
involved in cell adhesion and have cytoplasmic signaling and/or
nuclear roles.
To date, the signal(s) that trigger p120ctn nuclear transloca-
tion and subsequent export remains unknown. One study
suggesting a trigger for p120ctn nuclear localization implicates
the transmembrane adhesion protein Mucin-1 [35]. Li and Kufe
[35] detected an interaction between p120ctn and the Mucin-1
cytoplasmic domain and demonstrated that overexpression of
Mucin-1 correlated with increased nuclear localization of
p120ctn. Interestingly Mucin-1 is aberrantly overexpressed in
many human carcinomas and this correlates with its interaction
with β-catenin and increased nuclear β-catenin [36,37].
Evidence linking Mucin to a signaling role with cadherins
and catenins is further provided by the findings that (i) Mucin-1
has been implicated in the inhibition of E-cadherin-mediated
cell–cell adhesion and (ii) the epidermal growth factor receptor
and c-Src tyrosine kinase both phosphorylated the Mucin-1
cytoplasmic tail and regulated its interaction with β-catenin
[38–40]. Whether these kinases also regulate the interaction of
Mucin-1 with p120ctn remains to be determined. However, one
possible scenario is that Mucin-1 overexpression in carcinomas
triggers the nuclear localization of p120ctn, which is then unable
to stabilize E-cadherin at the cell membrane. This may
eventually contribute to decreased cell–cell adhesion and
promote tumor metastasis.
Finally, another possibility that needs to be considered is that
an adhesion signal (i.e. cadherin engagement or disengagement,
or cell–cell contact itself) triggers the translocation of p120ctn to
the nucleus. This idea is appealing because p120ctn is not
anchored to the actin cytoskeleton like β-catenin and plakoglo-
bin. Identification of the trigger or event that causes p120ctn
nuclear translocation will be key to elucidating the signaling
pathway(s) involving p120ctn and Kaiso and would provide
significant insight on the role of nuclear p120ctn. Characteriza-
tion of the pathway and its components may also indicate
whether p120ctn and Kaiso are involved in cross-talk between
the Wnt and E-cadherin signaling pathways (see below).
3. p120ctn's nuclear binding partner, Kaiso, is a POZ-zinc
finger protein
Kaiso is a member of the BTB/POZ (Broad complex,
Tramtrak, Bric à brac/Pox virus and zinc finger) subfamily of
zinc finger proteins, hereafter POZ-ZF proteins. Vertebrate
members of this rapidly growing family of DNA-binding
transcription factors (e.g. BCL-6, PLZF, HIC-1, FAZF, APM1,
MIZ-1, ZBTB7, Champignon) are implicated in embryogenesis
and cancer [41–47]. For example, BCL-6 and PLZF are
oncoproteins that are causally linked to non-Hodgkin's
lymphoma and acute promyelocytic leukemia respectively
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multiple human cancers [43,44,53–55] while HIC-1 and APM1
are candidate tumor suppressors in several cancers [47,48].
With respect to vertebrate development, BCL-6 appears to be a
master regulator of B-cell germinal center formation and B-
lymphocyte proliferation and terminal differentiation [56],
PLZF has a role in limb and skeletal development and
spermatogenesis [57–59], and HIC-1 is implicated in mamma-
lian embryonic development and the neuronal disorder Miller–
Dieker syndrome [60].
The defining feature of the POZ-ZF protein family is the
highly conserved amino-terminal hydrophobic POZ protein–
protein interaction domain that mediates homodimerization and
heterodimeric interactions with other POZ and non-POZ
proteins (Fig. 1). Like other POZ-ZF proteins, Kaiso has the
characteristic conserved POZ domain at its amino-terminus
where it facilitates Kaiso homodimerization [3] and hetero-
dimerization with diverse proteins such as the vertebrate
insulator protein CTCF [61] and the HDAC corepressor
NCoR [62]. Additionally, Kaiso has three DNA-binding C2H2
zinc fingers at its carboxy-terminus. Interestingly it is the C-
terminal tail of Kaiso encompassing the zinc finger motif, and
not its POZ domain, that binds to p120ctn [3]. In addition, Kaiso
has two highly acidic regions between its POZ and ZF domains.
Notably, acidic regions are implicated in transcriptional
activation [63,64] and the finding that Kaiso activates
transcription of the neuromuscular gene rapsyn is consistent
with the presence of these two acidic domains [17]. This dual
transcriptional regulation (activation and repression) by Kaiso is
also consistent with the fact that although the majority of POZ-
ZF proteins are transcriptional repressors, some are activators
(MIZ-1) while others such as ZF-5 both activate and repress
natural promoters [65,66]. The transcriptional properties of
Kaiso will be discussed in detail below.
In contrast to p120ctn but as to be expected for a putative
transcription factor, Kaiso was frequently detected in the nuclei
of various mammalian cell lines, tumor and non-tumor derived.
Recently however, immunohistochemical analyses of human
normal and tumor tissues revealed that Kaiso was predominantly
localized in the cytoplasm rather than in cell nuclei or Kaiso was
totally absent [67]. One explanation is that perhaps Kaiso is
similar to MAP kinase or other transcription factors that
normally reside in the cytoplasm until they are post-translation-
ally modified (e.g. phosphorylated) and signaled to translocate
to the nucleus. Interestingly, Kaiso's cytoplasmic localization
almost always coincided with cytoplasmic p120ctn and Kaiso's
subcellular localization appeared to be regulated by the tumor
microenvironment. Nevertheless, Kelly et al. determined that
Kaiso has one highly basic autonomous nuclear localization
signal “NLS” [68]. This NLS is required for nuclear localization
of Kaiso and is conserved in Kaiso proteins from diverse species
(Xenopus, human and mouse). The in vitro binding and
coprecipitation of Kaiso with Importin-α further suggests that
unlike β-catenin and p120ctn, Kaiso's nuclear import utilizes the
classical Importin-α/β nuclear import mechanism [68].
Finally, Kaiso also has multiple putative proline-dependent
serine/threonine phosphorylation sites (Fig. 1, asterisks). In fact,Kaiso is predominantly phosphorylated on serine residues (JM
Daniel and AB Reynolds, unpublished data), but the upstream
signaling pathway(s) and kinase(s) that target Kaiso for
phosphorylation are currently unknown. Identification of these
signaling pathways and/or kinases would significantly add to
our understanding of Kaiso function and reveal whether
phosphorylation of Kaiso regulates its subcellular localization
and/or interaction with binding partners such as p120ctn.
4. Kaiso is a bimodal transcription repressor
Initially, it was postulated that like any other POZ-ZF
transcription factor, Kaiso would recognize and bind a specific
DNA consensus sequence. Surprisingly however, and unlike
any of the previously characterized POZ proteins, Kaiso
exhibited dual-specificity DNA binding: Kaiso recognized a
sequence-specific DNA consensus, TCCTGCnA, as well as
methylated CpG-dinucleotides [69,70]. Interestingly, only zinc
fingers 2 and 3 are necessary and sufficient for DNA-binding to
either sequence in vitro [69]. Since the p120ctn-binding site
encompasses the Kaiso zinc finger domain, it was not surprising
to find that p120ctn inhibited Kaiso's DNA-binding in vitro and
in vivo [69,71], and abrogated Kaiso-mediated repression of a
minimal promoter [18,71]. This provided the first experimental
evidence linking nuclear p120ctn to the regulation of gene
expression in a manner reminiscent of β-catenin. Interestingly, a
subset of putative Kaiso target genes include the β-catenin/TCF
targets cyclinD1 and matrilysin (our unpublished data and
[71,72]), and this has implicated Kaiso and p120ctn as indirect
regulators of the Wnt signaling pathway. Other putative target
genes identified to date include the neuromuscular gene rapsyn
[17], MTA2, Wnt-11 and siamois [62,72,73]. Interestingly,
while Kaiso functions as a transcriptional repressor in the
context ofWnt-11, siamois, matrilysin and cyclinD1, Kaiso acts
as a transcriptional activator of rapsyn [17]. The biological
relevance of this difference remains unknown, but it highlights
the complexity of Kaiso function in vertebrates.
Mechanistically, Kaiso functions like most POZ-ZF proteins
as a histone-deacetylase-dependent transcriptional repressor.
Histone deacetylases (HDACs) catalyze the amino-terminal
deacetylation of histones and this modification then facilitates a
closed chromatin conformation that prohibits gene transcrip-
tion, reviewed in [74,75]. HDACs are normally found in
multiprotein complexes with transcriptional corepressors and
they are recruited to specific DNA promoter regions by their
transcriptional corepressors or by sequence-specific transcrip-
tion factors. Kaiso recruits the macromolecular histone
deacetylase (HDAC) corepressor complex that includes an
HDAC and the corepressors mSin3A, silencing mediator of
retinoic and thyroid hormone receptors (SMRT), or nuclear
receptor co-repressor (NCoR) [62,70,71,76]. Yoon et al. [62]
detected a direct interaction between Kaiso and the corepressor
NCoR, which bound and recruited HDAC3 to methyl-CpG
repressor complexes. However they failed to detect a Kaiso–
mSin3A interaction in their system. In contrast, Elzi and
Eisenman (personal communication) identified Kaiso as an
mSin3A binding partner during a yeast-two-hybrid screen for
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endogenous interaction by coimmunoprecipitation and Western
blot analyses using Kaiso and mSin3A-specific antibodies.
Interestingly, the Kaiso–mSin3A interaction was detected in
epithelial (HCT116) but not fibroblast (NIH 3T3) cell lines. The
relevance, if any, of this observation, remains unknown but it is
noteworthy that the p120ctn–Kaiso interaction also appears to be
epithelial cell type-specific (our unpublished data). It is
provocative to speculate that perhaps the Kaiso–mSin3A
repressor complex regulates genes that define the epithelial
phenotype, inhibit cell motility or enhance cell adhesionwhereas
the Kaiso–NCoR interaction may be involved in more global
methyl-CpG-related epigenetic gene silencing. Another inter-
pretation of these observations is that Kaiso–mSin3A com-
plexes are linked to sequence-specific promoter repression
whereas Kaiso–NCoR complexes are linked to methyl CpG-
promoter repression. Since these two possibilities may not be
mutually exclusive, this dichotomy in Kaiso corepressor
recruitment (i.e. Kaiso/NCoR versus Kaiso/mSin3A), coupled
with Kaiso's bimodal DNA-binding ability, adds another level of
complexity to Kaiso-mediated gene regulation.
5. p120ctn regulation of Kaiso-mediated transcription
The overlap of the p120ctn binding site with the Kaiso DNA-
binding ZF domain provided the first clue that nuclear p120ctn
possibly functioned in regulating Kaiso DNA-binding and
ultimately transcriptional activity. This hypothesis was con-
firmed using EMSA, chromatin IP, RNAi and artificial/minimal
promoter–reporter methodologies which demonstrated that
nuclear p120ctn was involved in regulating Kaiso DNA-bindingFig. 2. Model depicting the E-cadherin–catenin cell adhesion complex and signali
established downstream effector of the Wnt signaling pathway, whereas the pathway
p120ctn is phosphorylated in response to receptor tyrosine kinase (RTK) and Src sign
and matrilysin. One role of nuclear p120ctn is to inhibit Kaiso's transcriptional rep
transcriptional activity.and transcriptional activity in the context of the sequence-
specific consensus site [18,71]. More importantly, the conver-
gence of p120ctn and Kaiso on a subset of Wnt/β-catenin target
genes (cyclinD1, matrilysin, siamois) now implicates Kaiso and
p120ctn as modulators of the canonical Wnt signaling pathway
[71,72], (Fig. 2). While the evidence indicated that the p120ctn
regulatory effect on Kaiso was via inhibition of Kaiso DNA-
binding, it remained possible that p120ctn was functioning by
sequestering Kaiso in the cytosol. However, Kelly et al. found
that NLS-defective p120ctn, which was stranded in the
cytoplasm, failed to inhibit Kaiso transcriptional repression
activity [18]. This indicated that nuclear localization of p120ctn
was necessary for its inhibitory effect on Kaiso.
To date, most studies have concentrated on the effects of
p120ctn on Kaiso-mediated repression of minimal promoters
possessing the sequence-specific consensus sites but not
promoters possessing the methyl-CpG sites. The question thus
remains - does p120ctn also regulate Kaiso-mediated methyl-
CpG-dependent gene silencing? Another unanswered question
is, what are the effects of p120ctn on Kaiso-mediated
transcriptional activation? Is it inhibitory or stimulatory?
These questions need to be addressed to provide further insight
on nuclear p120ctn function, its role in gene expression and
potential role as modulator of the Wnt signaling pathway (see
below).
6. Kaiso-related transcription factors: regulation by
p120ctn?
Recently two human proteins, ZBTB38 and ZBTB4/Kaiso-
like 1, were identified with high sequence homology to Kaiso inng pathways involving the Armadillo catenins β- and p120ctn. β-catenin is an
involving p120ctn and its nuclear translocation has yet to be elucidated. However
aling. Kaiso inhibits β-catenin/TCF activation of target genes such as cyclinD1
ression activity. The Kaiso binding partner CTCF may also modulate Kaiso's
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more related to each other than either is to Kaiso. The greatest
sequence conservation between all three proteins occurs in the
first two zinc fingers and there is little sequence homology
outside of the zinc finger domain or the POZ domain.
Interestingly however, like Kaiso, ZBTB4 and ZBTB38 both
bind methylated DNA in vitro, but unlike Kaiso, which binds
methylated-CpG pairs, ZBTB4 and ZBTB38 bind single
methylated-CpGs. Furthermore ZBTB4 but not ZBTB38 also
binds the consensus Kaiso binding site (KBS) TCCTGCnA
[77]. This makes ZBTB4 most similar to Kaiso with respect to
its bimodal DNA-binding activity. Sequence comparison of the
ZF domain revealed that there are only four (4) amino acid
residues conserved between Kaiso and ZBTB4 but not between
Kaiso and ZBTB38, hence these residues may dictate their
DNA-sequence recognition and/or binding to the KBS. Crystal
structure and biochemical analyses would shed significant light
on this unique bi-modal DNA-binding property of Kaiso and
ZBTB4.
To date little else is known about these Kaiso-like proteins
except that they homo- and heterodimerize with each other via
their ZF domain but they do not heterodimerize with the Kaiso
ZF domain [77]. Whether ZBTB4 and ZBTB38 heterodimerize
with Kaiso via their POZ domains is unknown. Such
interactions would add another level of complexity to Kaiso-
mediated transcriptional regulation of target genes and needs to
be considered in all future analyses. Surprisingly, neither
protein interacted with p120ctn in a yeast two-hybrid interaction
assay [77]. This suggests that although the p120ctn binding site
encompasses the ZF domain that is highly conserved in all three
proteins, amino acid residues outside the ZF domain probably
contribute to the specificity of the p120ctn–Kaiso interaction. It
is also possible that the 16 totally conserved residues in the ZF
domains of ZBTB4 and ZBTB38, but which are unique in
Kaiso, contribute to the specificity of the p120ctn–Kaiso
interaction. Hence although ZBTB4 and ZBTB38 may compete
with Kaiso for DNA-binding to target genes and may have
redundant functions, they appear to be subject to different
regulatory controls than Kaiso.
7. Impact of p120ctn on other Kaiso activities or
interactions
Thus far the only other nuclear role for Kaiso is as a
potential regulator of CTCF, a vertebrate insulator protein and
multifunctional, zinc finger phosphoprotein implicated in
promoter activation and repression, hormone-responsive gene
silencing, methylation-dependent chromatin insulation and
genomic imprinting, reviewed in [78–80]. Insulators are
DNA elements that partition DNA into transcriptionally active
and inactive regions using two mechanisms. They act as barrier
elements that prevent heterochromatin spread or as enhancer
blockers (e.g. CTCF) that prevent enhancers from activating
gene transcription.
Interestingly, the Kaiso–CTCF interaction was discovered in
two independent studies: one looking for Kaiso binding partners
(Daniel and colleagues) and one looking for CTCF bindingpartners (Defossez and colleagues). The interaction occurs via
the Kaiso POZ domain and a CTCF C-terminal region that is
implicated in its insulator activity [61]. The Kaiso–CTCF
interaction was specific since CTCF did not interact with the
POZ domain of BCL-6, PLZF, HIC-1 or FAZF in a yeast two-
hybrid interaction assay [61]. Interestingly a consensus Kaiso
binding site (KBS) was present in close proximity to the CTCF
binding site in the human 5′ β-globin gene insulator element,
raising the possibility that Kaiso regulated CTCF function at this
locus. Indeed it was found that the presence of an intact KBS
reduced the enhancer-blocking activity of CTCF, and this result
implicated Kaiso as a negative regulator of CTCF insulator
activity [61]. This raises several important questions. First, is this
a general phenomenon and are all CTCF-regulated insulators
modulated by Kaiso or is Kaiso's inhibition of CTCF specific to
the β-globin locus? Second, does p120ctn play a role in
regulating Kaiso–CTCF insulator activity? Third, does CTCF
modulate Kaiso transcriptional activity and is CTCF's associ-
ation with Kaiso mutually exclusive of p120ctn binding? The
answers to these questions may complicate our understanding of
Kaiso's mechanism(s) of action, but at a minimum they will
enhance our understanding of Kaiso function in general.
8. Cross-talk between p120ctn/Kaiso signaling and
canonical Wnt/β-catenin/TCF signaling in development
Significant insight regarding the role of Kaiso in vertebrate
development was gained using the Xenopus laevis model
system. Kim et al. [73] found that Kaiso-depleted Xenopus
embryos had gastrulation defects in mesodermal involution,
blastopore closure and convergent extension [73]. Interestingly,
depletion of another POZ-ZF protein, Champignon, produced
similar convergent extension defects during Xenopus develop-
ment [81] and this raises the possibility that Kaiso and
Champignon play important roles in regulating Xenopus conver-
gent extension in gastrulation. Whether Kaiso and Champignon
perform this role in all vertebrates remains to be determined.
The structural similarity of p120ctn to β-catenin initially led
scientists to postulate that perhaps p120ctn also induced a
secondary axis in Xenopus embryos. However, it was found that
p120ctn ventral overexpression had no effect on Xenopus axis
formation and it was concluded that p120ctn was not directly
linked to canonical Wnt signaling [82]. Intriguingly however,
p120ctn depletion or p120ctn overexpression in Xenopus also
produced blastopore closure and convergent extension defect
phenotypes [83,84]. While the p120ctn overexpression pheno-
type is consistent with p120ctn negatively regulating Kaiso, it is
puzzling that p120ctn depletion, which should allow endogenous
Kaiso to function normally and repress its target genes, also
produced a convergent extension defect in Xenopus. One
possible explanation is that the p120ctn-depletion phenotype
is attributable to the effects of p120ctn on Rho GTPases.
Unfortunately, the subcellular localization of p120ctn or Kaiso in
Xenopus cells was not examined in either study, making it
difficult to determine the contribution, if any, of nuclear p120ctn
to the Kaiso-depletion or p120ctn-overexpression phenotype.
Nevertheless, the Kaiso-depleted embryos exhibited increased
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canonical Wnt that signals through Rho GTPases and plays a
prominent role in morphogenesis and cell adhesion [85],
whereas siamois is a transcription factor and downstream target
of canonical Wnt signaling, and is essential for formation and
maintenance of the Spemann organizer and dorsoanterior
development in Xenopus [86].
The deregulation of non-canonical and canonical Wnt targets
as a result of Kaiso depletion provided the first clues implicating
Kaiso in non-canonical and canonical Wnt signaling. Indeed,
Park et al. [72] subsequently found that Kaiso overexpression
could rescue the Xenopus axis-duplication phenotype caused by
β-catenin overexpression [87]. This finding, coupled with the
fact that Kaiso inhibits theβ-catenin/TCF-mediated activation of
someWnt target genes [71,72], now places Kaiso at the nexus of
canonical and non-canonical Wnt signaling and adds a new
dimension to the regulation of vertebrate axis formation and
development. In fact, while the importance of canonical Wnt
signaling in vertebrate developmental events such as axis
specification and tissue patterning has been long accepted, it is
only recently that the importance of non-canonicalWnt signaling
in vertebrate development has emerged [88–91]. For example, a
recent study by Tao et al. [89] has linked the non-canonical
Wnt-11 to canonical Wnt signaling in Xenopus development.
To date there are over fifty putative Wnt/β-catenin target
genes (http://www.stanford.edu/~rnusse/pathways/targets.html)
and it remains to be determined whether p120ctn/Kaiso
signaling also regulates the majority of these Wnt/β-catenin
targets. It is possible that p120ctn/Kaiso signaling only regulates
a subset of Wnt/β-catenin targets, for example those directly
involved in specific biological processes such as cell prolifer-
ation and motility. Nevertheless, elucidation of the signaling
pathway regulating the p120ctn–Kaiso interaction and nuclear
translocation of p120ctn will shed significant light on the
physiological role of p120ctn and Kaiso and the relevance of
cross-talk between the p120ctn/Kaiso pathway and the Wnt/β-
catenin/TCF pathway.
Another outstanding question is whether these are truly
parallel pathways and whether there is bi-directional cross-talk
between the two pathways, i.e. do any components of the Wnt/
β-catenin pathway also regulate or impact p120ctn/Kaiso
signaling? Thus far the genes characterized as co-regulated by
β-catenin/TCF and p120ctn/Kaiso were first implicated as
potential Kaiso targets due to the presence of the Kaiso-binding
site (KBS) in their promoters. However it is possible that
Kaiso's regulation of some Wnt/β-catenin target genes may be
mediated by Kaiso's recognition of methylated-CpGs rather
than the sequence-specific KBS. Furthermore it is intriguing
that in contrast to β-catenin, p120ctn does not appear to be a
transcriptional coactivator per se. This is consistent with TCF
being an HMG (high mobility group) transcriptional repressor
that directly alters DNA conformation. Hence TCF is
mechanistically distinct from Kaiso, which is a “classic”
transcription repressor that recruits corepressors to facilitate
chromatin conformational changes. Consequently p120ctn acts
by inhibiting Kaiso DNA-binding whereas β-catenin behaves
as a coactivator but does not affect TCF DNA-binding.9. Kaiso in tumorigenesis
Like the majority of POZ-ZF proteins, Kaiso is implicated in
cancer and the fact that several putative Kaiso target genes
(MTA2, MMP7, siamois, cyclinD1) are linked to cell prolifer-
ation or tumor metastasis provided the first clues that Kaiso may
play a role in tumorigenesis. Specifically, three of the known
Wnt/β-catenin/TCF target genes, siamois, cyclinD1 and ma-
trilysin [92–95], are implicated as potential Kaiso targets based
on (i) the presence of the consensus Kaiso site in their
promoters, (ii) the association of Kaiso with their promoter
DNA in vivo, and (iii) the Kaiso-mediated repression of their
wild type minimal promoters in luciferase-reporter assays
[71,72]. The recent finding that Kaiso inhibits β-catenin-
mediated activation of the metastasis-promoting gene matrily-
sin [71] and the observation that Kaiso rescues the β-catenin-
induced Xenopus axis duplication phenotype [72], further
implicate Kaiso as a negative regulator of the Wnt/β-catenin
pathway that is inextricably linked to many human tumors.
Together these data support the hypothesis that the p120ctn–
Kaiso and β-catenin-TCF pathways converge to regulate genes
involved in tumorigenesis. Several other studies support a role
for Kaiso in tumorigenesis. For example, the S100A4/metasta-
sin gene that is linked to cell adhesion and tumor metastasis
[96], was recently implicated as a potential Kaiso target gene
when it was discovered that Kaiso binds CpG-methylated sites
in its promoter [70]. Additionally, a recent study reported that
more than 30% of genes upregulated in Kaiso-depleted Xeno-
pus embryos are involved in cell growth control and chromatin
remodelling [97]. Collectively these studies lend credence to the
hypothesis that Kaiso may be a tumor suppressor.
It was therefore surprising that despite several studies
supporting a role for Kaiso in tumorigenesis and vertebrate
development, a recent Kaiso knock-out study by Prokhortch-
ouk et al. [98] revealed that Kaiso-deficient mice were viable,
had no detectable developmental defects and did not develop
tumors. This discrepancy with the Kaiso-null Xenopus study
[72] is most likely explained by the possible redundancy
conferred by the Kaiso-related proteins ZBTB4 and ZBTB38
that are present in mammals but not in Xenopus [77]. In fact,
since ZBTB4 is most similar to Kaiso and has bimodal DNA-
binding properties and recognizes the sequence-specific Kaiso
binding site, it is very likely that ZBTB4 compensated for
Kaiso loss in the Kaiso-null mice. Hence double knock-out
mice (e.g. Kaiso−/− ZBTB4−/− or Kaiso double knock-outs
with different methyl-binding proteins) need to be generated
and analysed to test this hypothesis. Interestingly however,
when the Kaiso-null mice were crossed with the intestinal
tumor-susceptible ApcMin/+ mice, intestinal tumor onset was
delayed and polyp size was reduced [98]. This suggested that
Kaiso did play a role in intestinal tumorigenesis, perhaps in
tumor initiation. While the evidence is quite strong that
p120ctn/Kaiso signaling converges on Wnt/β-catenin targets
during Xenopus development, it is now necessary to experi-
mentally validate that the pathways also functionally converge
in mammals. For example, if the p120ctn/Kaiso and Wnt/β-
catenin pathways do converge in mammals, one would predict
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transgenic mice would produce offspring with a significantly
reduced number of intestinal tumors.
10. Conclusions and perspectives
In the past 5 years, significant progress has been made in
elucidating the role of nuclear p120ctn. Several studies have
confirmed the existence of a nuclear p120ctn pool, but unlike the
classical β-catenin, nuclear p120ctn seems to be transient and
difficult to detect. Nevertheless, the most significant advance-
ment in our understanding the role of nuclear p120ctn has been
the discovery that it regulates the POZ-ZF transcription
repressor Kaiso and that p120ctn may also modulate Wnt/β-
catenin signaling via its convergence with Kaiso on a subset of
Wnt/β-catenin/TCF target genes (Fig. 2).
However, many key unanswered questions need to be
addressed: (i) Is p120ctn itself a transcription activator or simply
an inhibitor of transcription factors? (ii) What event or signal
triggers the nuclear entry and exit of p120ctn, and why is nuclear
p120ctn seldom detected? (iii) Does the p120ctn Arm domain
possess intrinsic nuclear transport ability and is p120ctn
involved in the nucleocytoplasmic trafficking of Kaiso or
other proteins? (iv) Is the sole role of nuclear p120ctn to regulate
Kaiso function/transcriptional activity from sequence-specific
sites, or does p120ctn also regulate Kaiso transcriptional
repression through methylated-CpG sites?
Finally, as mentioned earlier, the subcellular localization of
Kaiso appears dependent on the tissue microenvironment. If the
tissue microenvironment also impacts p120ctn subcellular
localization, this may explain why, in contrast to β-catenin that
is readily detected in the nuclei of many human tumor cells, the
subcellular localization of p120ctn in human tumors is quite
heterogeneous and seldom detected in tumor nuclei. It is also
possible that exclusively nuclear p120ctn is (i) detrimental to
normal and tumor cell function/viability, (ii) does not contribute
to the tumorigenic phenotype, or (iii) transient and under stringent
regulation. Nonetheless, despite these outstanding issues, it
appears that like the classical β-catenin, p120ctn is a multifunc-
tional Armadillo catenin with roles at the plasma membrane
(adhesion), in the cytoplasm (cytoskeletal regulation) and in the
nucleus (gene regulation). Future studies using cell culture
systems and mouse models should help clarify the relevance of
nuclear p120ctn and Kaiso in development and tumorigenesis.
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